C20:2-OH/C18:2-DC

There is 1 paper on C20:2-OH/C18:2-DC in aging research: 1 trial in people.

Biomarker

1 paper studies it2 findings

See all 1 papers on C20:2-OH/C18:2-DC

  • Human trial1

Interventions

1

Exercise

downin humans1

1 study
  1. Exercise decreases C20:2-OH/C18:2-DC in humans (fold-change 0.7136 vs. 1.741).

    “Levels of long-chain acylcarnitine C20:2-OH/C18:2-DC were reduced in the Intervention group by a magnitude of 0.7136 (fold-change) but increased in the Control group by a magnitude of 1.741 (mean difference in fold-change 1.028, p < 0.001, age-adjusted p = 0.004).”

    Human trialtwelve weeks

    Effects of short-term moderate intensity exercise on the serum metabolome in older adults: a pilot randomized controlled trial

    Communications medicine

  2. Exercise decreases C20:2-OH/C18:2-DC in humans (middle-aged adults without cardiovascular disease) (mean difference -1.028, p = 0.004).

    “Long-chain acylcarnitine C20:2-OH/C18:2-DC was reduced in the Intervention group by a magnitude of 0.714 but increased in the Control group by a magnitude of 1.742 (mean difference -1.028 age-adjusted p = 0.004).”

    Human trialmiddle-aged adults without cardiovascular diseaseserumtwelve weeksfemalesn = 29

    Effects of short-term moderate intensity exercise on the serum metabolome in older adults: a pilot randomized controlled trial

    Communications medicine

More on Exercise

Latest